financetom
Business
financetom
/
Business
/
Twilio Q1 Non-GAAP Earnings, Revenue Rise; Sets Q2 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Twilio Q1 Non-GAAP Earnings, Revenue Rise; Sets Q2 Guidance
May 25, 2025 11:54 PM

05:52 PM EDT, 05/01/2025 (MT Newswires) -- Twilio ( TWLO ) reported Q1 non-GAAP earnings late Thursday of $1.14 per diluted share, compared with $0.80 a year earlier.

Analysts polled by FactSet expected $0.96.

Revenue for the quarter ended March 31 was $1.17 billion, up from $1.05 billion a year earlier.

Analysts surveyed by FactSet expected $1.14 billion.

The company set Q2 non-GAAP adjusted EPS guidance of $0.99 to $1.04 on revenue of $1.18 billion to $1.19 billion. Analysts expect EPS of $1.04 on revenue of $1.17 billion.

Shares were up nearly 8% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SEI Investments Selected by Arrow Global to Support Luxembourg Private Credit Fund
SEI Investments Selected by Arrow Global to Support Luxembourg Private Credit Fund
Nov 29, 2024
08:41 AM EST, 11/29/2024 (MT Newswires) -- SEI Investments ( SEIC ) said Friday it was selected by Arrow Global Group to support its fund administration, loan operations, and investor services for its private credit fund in Luxembourg. SEI's technology is expected to streamline the onboarding process as well as provide data insights and enhanced transparency, according to Meera Savjani,...
Silo Pharma Collaborates With Kymanox to Develop Subcutaneous Ketamine Device for Potential Pain Relief
Silo Pharma Collaborates With Kymanox to Develop Subcutaneous Ketamine Device for Potential Pain Relief
Nov 29, 2024
08:41 AM EST, 11/29/2024 (MT Newswires) -- Silo Pharma Inc ( SILO ) said Friday it has agreed to collaborate with Kymanox to design and develop a subcutaneous insertion device for SP-26, its ketamine-loaded implant for potential treatment of fibromyalgia and chronic pain. Financial terms were not disclosed. Under the agreement, Kymanox will come up with a proof-of-concept design followed...
Oil Prices Mixed Early Following OPEC+ Decision to Delay Planned Meeting
Oil Prices Mixed Early Following OPEC+ Decision to Delay Planned Meeting
Nov 29, 2024
08:38 AM EST, 11/29/2024 (MT Newswires) -- Oil prices were mixed early on Friday as expectations OPEC+ will delay production increases currently scheduled to begin in January ease worries over an oversupplied market. West Texas Intermediate crude for January delivery was last seen up US$0.20 to US$68.92 per barrel, while January Brent oil was down US$0.14 to US$73.14. OPEC+ on...
Lithium Americas to Redomicile in Switzerland as Lithium Argentina AG
Lithium Americas to Redomicile in Switzerland as Lithium Argentina AG
Nov 29, 2024
08:39 AM EST, 11/29/2024 (MT Newswires) -- Lithium Americas (LAAC) said Friday it plans to establish its corporate domicile in Switzerland, adopting the new name Lithium Argentina AG, pending shareholder, stock exchange, and court approval in early 2025. Switzerland was chosen for its strategic, legal, and commercial advantages after a review of the company's business and corporate structure. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved